Immune test before pancreatic surgery to predict leaks
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at your immune system before pancreatic surgery to predict if you might develop a common post-surgery complication called a pancreatic leak (where digestive juices escape the pancreas). The goal is to see if simple blood tests before surgery can help doctors plan better care and reduce risks for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be scheduled to have surgery to remove part of your pancreas (to try to cure your condition).
- If the surgery is planned to remove the whole pancreas before the operation, you may not qualify, but if the decision is made during surgery, you might still be able to join.
- You need to be covered by a national health insurance scheme (like Sécurité Sociale in France).
- You must be able to give your consent and follow the study's check-ups; being in an emergency or under legal protection would prevent participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how tiny particles in blood (“exosomes”) carry signals between cells in people having pancreatic surgery. The goal is to understand these signals in different pancreatic conditions and treatment situations, which may help future care.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study uses a blood test to look at how your immune system responds, which may help tell if chronic pancreatitis could turn into pancreatic cancer. It aims to find better ways to monitor people with chronic pancreatitis and catch cancer earlier.
This study looks at blood markers and gut bacteria to better understand the risk of pancreatic cancer in people with chronic pancreatitis (long-term pancreas inflammation). It may help detect cancer earlier or guide prevention.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.